Three-Part Medtech Innovation Equation: The Thoracic Surgeon’s View
Executive Summary
Medtech advancements leading to cost savings and improved outcomes are the result of a confluence of three elements: technology, clinical processes, and the business case, according to consultant thoracic surgeon Aman Coonar.
You may also be interested in...
Intuitive’s da Vinci: Will Familiarity Breed Success?
Robotic soft-tissue MIS pioneer Intuitive Surgical continues to advance its offering in this disruptive area of medical technology. Having weathered an adverse incident-related storm, it is putting efforts into driving OUS business, broadening surgical applications, and convincing the doubters about robotic surgery’s place and role in the catalog of care delivery.
DTx And Drug Deal Sees Closed Loop Medicine And Teva Team Up On Precision Care
Medicines are still typically prescribed based on average effects in a population and rarely dose-optimized for the individual, says Closed Loop Medicine. The company sees a new strategic partnership with Teva UK as another step in advancing personalized medicine.
Swiss-EU Standoff Set To End? Medtechs Eye MRA Action
Negotiations aimed at renewing the close trading relationship and barrier-free mutual market access between Switzerland and the EU got underway on 19 March. Swiss medtech companies welcomed the move, stressing the need for the defunct mutual recognition agreement to be updated.